GENPACT LIMITED (NYSE:G) Files An 8-K Other EventsItem 8.01Other Events.
As previously disclosed, in March 2017, Genpact Limited (the “Company”) and its wholly-owned subsidiary, Genpact Luxembourg S.à r.l. (the “Issuer”), entered into an Indenture with Wells Fargo Bank, National Association, as trustee, to which the Issuer issued $350.0 million aggregate principal amount of its 3.700% Senior Notes due 2022 (the “Original Notes”). The Original Notes were sold in a transaction exempt from registration under the Securities Act of 1933, as amended, and are guaranteed on a senior unsecured basis by the Company.
In connection with the anticipated filing of a Registration Statement on Form S-4 relating to an offer to exchange the Original Notes for notes with terms identical to those of the Original Notes (except that such notes will not be subject to restrictions on transfer or the payment of additional interest), the Company is filing this Current Report on Form 8-K to include the condensed consolidating financial information of the Company and the Issuer specified by Rule 3-10 of Regulation S-X in the Company’s consolidated financial statements, and the notes thereto, originally filed on March 1, 2018 as part of the Company’s Annual Report on Form 10-K for the year ended December 31, 2017, and in the Company’s unaudited consolidated financial statements, and the notes thereto, originally filed on May 10, 2018 as part of the Company’s Quarterly Report on Form 10-Q for the three months ended March 31, 2018.
The consolidated financial statements, and the notes thereto, are set forth in Exhibit 99.1 to this Current Report on Form 8-K and replace and supersede those financial statements referenced in Part II, Item 8, and Part IV, Item 15, of the Company’s Annual Report on Form 10-K for the year ended December 31, 2017.
The unaudited consolidated financial statements, and the notes thereto, are set forth in Exhibit 99.2 to this Current Report on Form 8-K and replace and supersede those financial statements referenced in Part I, Item 1, of the Company’s Quarterly Report on Form 10-Q for the three months ended March 31, 2018.
Other than the addition of the condensed consolidating financial information of the Company and the Issuer specified by Rule 3-10 of Regulation S-X, no other changes to the Company’s previously issued financial statements have been made.
Item 9.01Financial Statements and Exhibits.
(d)Exhibits
The following exhibits are filed with this Current Report on Form 8-K:
Genpact LTD ExhibitEX-23 2 g-ex231_93.htm EX-23.1 g-ex231_93.htm Exhibit 23.1 Consent of Independent Registered Public Accounting Firm The Board of DirectorsGenpact Limited: We consent to the incorporation by reference in the registration statements (No. 333-210729) on Form S-3,…To view the full exhibit click here
About GENPACT LIMITED (NYSE:G)
Genpact Limited (Genpact) is engaged in providing digitally-powered business process management and services. The Company designs, transforms and runs a combination of processes, as well as provides solutions that combine elements of several of its service offerings. The Company offers various vertical activities, which include banking and financial services, insurance services, capital markets, consumer product goods services, life sciences and pharmaceutical services, infrastructure and manufacturing services, healthcare and high tech services. In addition to these vertical activities, it also offers finance and accounting (F&A) services, analytics and research, business consulting services, enterprise risk consulting, supply chain and procurement services, enterprise application services, information technology (IT) management services, and collections and customer services. The Company offers solutions, including Smart Enterprise Processes (SEP) and Genpact Digital.
